HKU1TMPRSS2

Lingshu Wang1, Jeswin Joseph2, Sheena Vasquez3

  • 1Vaccine Research Center; National Institutes of Allergy and Infectious Diseases; National Institutes of Health; Bethesda, Maryland, 20892; United States of America.

概括

研究人员描述了人类冠状病毒HKU1 (HCoV-HKU1) 与单克隆抗体的尖端相互作用. 他们发现了强大的中和抗体,准受体结合域,这对于开发通用冠状病毒疫苗至关重要.